Form 4 for ROIV Roivant Sciences Ltd.
Accepted 2024-07-30 00:00:00 ET · period of report 2024-07-26 · accession 0000950103-24-011229 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-07-30 | 2024-07-26 | ROIV | Venker Eric | Pres, COO | A - Grant | $0.00 | +204.0K | 650.3K | +46% | $0 |
| D | 2024-07-30 | 2024-07-26 | ROIV | Venker Eric | Pres, COO | A - Grant | $0.00 | +409.0K | 409.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2024-07-26 | A | A | 204,000 | $0.00 | 650,307 | D | — | — | (F1) Reflects an award of restricted stock units with respect to Common Shares, with a vesting commencement date of April 20, 2024, which service-vest (i) 25% on May 20, 2025 and (ii) in 12 successive equal quarterly installments thereafter, subject to the reporting person's continuous service through the applicable vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-07-26 | A | A | 409,000 | $0.00 | 409,000 | D | $10.80 · — to 2034-07-25 | 409,000 Common Shares | (F2) Reflects an award of stock options to purchase Common Shares with a vesting commencement date of May 20, 2024. These options vest and become exercisable (i) 25% on the first anniversary of the vesting commencement date and (ii) in 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service through each vesting date. |